Drug news
EU approvbes Plenadren (DuoCort Pharma) for Adrenal Insufficiency
The European Commission has granted marketing authorisation for dual-release hydrocortisone replacement therapy Plenadren (hydrocortisone, modified-release) from DuoCort Pharma as a once-daily oral treatment for adults with adrenal insufficiency � the first new therapy for the condition in 50 years. DuoCort Pharma is being acquired by Viro Pharma.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.